JP2020522502A5 - - Google Patents

Download PDF

Info

Publication number
JP2020522502A5
JP2020522502A5 JP2019566327A JP2019566327A JP2020522502A5 JP 2020522502 A5 JP2020522502 A5 JP 2020522502A5 JP 2019566327 A JP2019566327 A JP 2019566327A JP 2019566327 A JP2019566327 A JP 2019566327A JP 2020522502 A5 JP2020522502 A5 JP 2020522502A5
Authority
JP
Japan
Prior art keywords
liquid formulation
liquid
preparation according
formulation
liquid preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019566327A
Other languages
English (en)
Japanese (ja)
Other versions
JP7299166B2 (ja
JP2020522502A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/035473 external-priority patent/WO2018222922A1/en
Publication of JP2020522502A publication Critical patent/JP2020522502A/ja
Publication of JP2020522502A5 publication Critical patent/JP2020522502A5/ja
Priority to JP2023060542A priority Critical patent/JP7660603B2/ja
Application granted granted Critical
Publication of JP7299166B2 publication Critical patent/JP7299166B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019566327A 2017-06-02 2018-05-31 沈殿抵抗性低分子薬物製剤 Active JP7299166B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023060542A JP7660603B2 (ja) 2017-06-02 2023-04-04 沈殿抵抗性低分子薬物製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762514474P 2017-06-02 2017-06-02
US62/514,474 2017-06-02
PCT/US2018/035473 WO2018222922A1 (en) 2017-06-02 2018-05-31 Precipitation resistant small molecule drug formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023060542A Division JP7660603B2 (ja) 2017-06-02 2023-04-04 沈殿抵抗性低分子薬物製剤

Publications (3)

Publication Number Publication Date
JP2020522502A JP2020522502A (ja) 2020-07-30
JP2020522502A5 true JP2020522502A5 (https=) 2021-07-26
JP7299166B2 JP7299166B2 (ja) 2023-06-27

Family

ID=62705720

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019566327A Active JP7299166B2 (ja) 2017-06-02 2018-05-31 沈殿抵抗性低分子薬物製剤
JP2023060542A Active JP7660603B2 (ja) 2017-06-02 2023-04-04 沈殿抵抗性低分子薬物製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023060542A Active JP7660603B2 (ja) 2017-06-02 2023-04-04 沈殿抵抗性低分子薬物製剤

Country Status (14)

Country Link
US (2) US11020403B2 (https=)
EP (2) EP3630061B1 (https=)
JP (2) JP7299166B2 (https=)
KR (2) KR20240036128A (https=)
CN (2) CN117085022A (https=)
AU (2) AU2018275686B2 (https=)
BR (1) BR112019024987A2 (https=)
CO (1) CO2019013342A2 (https=)
DK (1) DK3630061T3 (https=)
ES (1) ES2982668T3 (https=)
IL (1) IL270979A (https=)
MX (1) MX2022012075A (https=)
TW (1) TWI813571B (https=)
WO (1) WO2018222922A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20240036128A (ko) 2017-06-02 2024-03-19 엑스에리스 파머수티클스, 인크. 침전 방지 저분자 약물 제제
KR20220024061A (ko) * 2019-05-31 2022-03-03 엑스에리스 파머수티클스, 인크. 비양성자성 극성 용매 중의 안정한 치료 조성물 및 이의 제조 방법
US20240335379A1 (en) * 2021-08-05 2024-10-10 Zydus Lifesciences Limited Stable pharmaceutical compositions of apomorphine
JP7606633B2 (ja) * 2022-04-14 2024-12-25 ウィズダム・ファーマスーティカル・カンパニー・リミテッド 医薬組成物及びアプレピタント注射液並びに凍結乾燥粉末注射剤
KR20250103637A (ko) * 2022-10-19 2025-07-07 엑스에리스 파머수티클스, 인크. 비양성자성 극성 용매를 사용한 서방형 주사용 제형
JP2025535354A (ja) 2022-10-19 2025-10-24 ゼリス ファーマシューティカルズ インコーポレイテッド 非プロトン性極性溶媒中の安定なレボチロキシン組成物

Family Cites Families (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016895A (en) 1958-08-01 1962-01-16 Pan American Lab Inc Injector for subcutaneous implantation of solids
DE2905979C2 (de) * 1979-02-16 1981-01-22 Carl-Jacob Gatzen Verwendung von acetylierten, destillierten Monoglyceriden zur Behandlung von Fettstoffwechselstörungen beim Menschen
US5260306A (en) 1981-07-24 1993-11-09 Fisons Plc Inhalation pharmaceuticals
GB2119248A (en) 1982-04-28 1983-11-16 John Kenneth Mcmullen Insulin formulations and method of producing them
CH664005A5 (de) 1984-05-19 1988-01-29 Glatt Maschinen & Apparatebau Verfahren zum trocknen eines teilchenfoermigen gutes und einrichtung zur durchfuehrung des verfahrens.
US5977082A (en) 1985-08-02 1999-11-02 Pharmacia & Upjohn Company Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US5124317A (en) 1985-08-02 1992-06-23 Farmitalia Carlo Erba S.P.A. Injectable ready-to-use solutions containing an antitumor anthracycline glycoside
US4927571A (en) 1987-05-18 1990-05-22 Liposome Technology, Inc. Preparation of injectable doxorubicin/liposome suspension
US4848094A (en) 1988-04-29 1989-07-18 Union Carbide Corporation Droplet freezing method and apparatus
US5031336A (en) 1989-08-31 1991-07-16 Abbott Laboratories Lyophilization of bulk pharmaceuticals
US5092843A (en) 1990-04-12 1992-03-03 Survival Technology, Inc. Dispersion multichamber auto-injector
CA2081474A1 (en) 1990-05-08 1991-11-09 Manzer Durrani Direct spray-dried drug/lipid powder composition
US5397771A (en) 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
ATE164080T1 (de) 1990-05-10 1998-04-15 Bechgaard Int Res Pharmazeutische zubereitung enthaltend n- glykofurole und n-äthylenglykole
US5208998A (en) 1991-02-25 1993-05-11 Oyler Jr James R Liquid substances freeze-drying systems and methods
JP3277342B2 (ja) 1992-09-02 2002-04-22 武田薬品工業株式会社 徐放性マイクロカプセルの製造法
ES2115201T3 (es) 1992-12-15 1998-06-16 Sanofi Sa Dispositivo para la preparacion de una solucion, de una suspension o de una emulsion de una sustancia medicinal.
US6051256A (en) 1994-03-07 2000-04-18 Inhale Therapeutic Systems Dispersible macromolecule compositions and methods for their preparation and use
US5652216A (en) 1994-05-26 1997-07-29 Novo Nordisk A/S Pharmaceutical preparation
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
NZ292980A (en) 1994-09-29 1999-02-25 Andaris Ltd Smooth, spherical water-soluble microparticles as therapeutic or diagnostic vehicles
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
US5932547A (en) 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
US5945128A (en) 1996-09-04 1999-08-31 Romano Deghenghi Process to manufacture implants containing bioactive peptides
IN184589B (https=) 1996-10-16 2000-09-09 Alza Corp
JP4642946B2 (ja) 1996-12-20 2011-03-02 アルザ コーポレイション ゲル組成物および方法
AU5719798A (en) 1996-12-31 1998-07-31 Inhale Therapeutic Systems, Inc. Processes for spray drying aqueous suspensions of hydrophobic drugs with hydrophilic excipients and compositions prepared by such processes
EP1285667B1 (en) 1997-11-18 2006-06-14 Uni-Pharma Kleon Tsetis Pharmaceutical Laboratories S.A. Pharmaceutical injectable solution of paracetamol and combinations of paracetamol with other active substances
FR2783433B1 (fr) 1998-09-18 2001-02-16 Delab Seringues pour l'administration de formulations pateuses ou semi-solides
SE9803662D0 (sv) 1998-10-26 1998-10-26 Pharmacia & Upjohn Ab Autoinjector
DE19851777A1 (de) * 1998-11-10 2000-05-11 Basf Ag Verwendung von Estern oder Amiden hydroxylierter Carbonsäuren als Solubilisatoren
US6199297B1 (en) 1999-02-01 2001-03-13 Integrated Biosystems, Inc. Lyophilization apparatus and methods
US7919109B2 (en) 1999-02-08 2011-04-05 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US6253463B1 (en) 1999-04-26 2001-07-03 Niro A/S Method of spray drying
US6309663B1 (en) 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US7651703B2 (en) 1999-10-15 2010-01-26 Genentech, Inc. Injection vehicle for polymer-based formulations
US7582311B1 (en) 1999-10-15 2009-09-01 Genentech, Inc. Injection vehicle for polymer-based formulations
US6478776B1 (en) 2000-04-05 2002-11-12 Biocardia, Inc. Implant delivery catheter system and methods for its use
EP1187602A4 (en) 2000-04-18 2004-09-15 Peptron Inc SUSTAINABLE RELEASE INJECTABLE PHARMACEUTICAL COMPOSITION AND METHODS OF PREPARING THE SAME
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
NZ523385A (en) 2000-06-28 2005-09-30 Atul J Biodegradable vehicles and BAS-loaded delivery systems for use as biodegradable fillers and/or spacers, e.g. artificial skin
EP1310252A4 (en) 2000-08-18 2009-06-10 Takeda Pharmaceutical INJECTIONS
RO120121B1 (ro) 2000-12-18 2005-09-30 Elena Ionaşcu Soluţie injectabilă, cu efect antiinflamator, procedeu de obţinere şi metodă de tratament a bolilor autoimune
US8166969B2 (en) 2001-03-06 2012-05-01 Texas Research International, Inc. Chemically and biologically resistant hydration system
DK1435945T3 (da) 2001-06-05 2008-12-01 Ronald Aung-Din Topisk migræne terapi
US6676958B2 (en) 2001-06-19 2004-01-13 Advanced Bioadjuvants, Llc Adjuvant composition for mucosal and injection delivered vaccines
EP1411861B1 (en) 2001-06-29 2012-04-04 Medgraft Microtech, Inc. Biodegradable injectable implants and related methods of manufacture and use
US20040142043A1 (en) 2001-07-09 2004-07-22 Atsushi Maeda Sustained-release compositions for injection and process for producing the same
US6733813B2 (en) 2001-08-02 2004-05-11 Ocean Spray Cranberries, Inc. Process for producing acids-enriched juice and acids-reduced juice
BR0212833A (pt) * 2001-09-26 2004-10-13 Baxter Int Preparação de nanopartìculas de tamanho submìcron através de dispersão e de remoção de solvente ou de fase lìquida
DE60239952D1 (de) 2001-11-14 2011-06-16 Durect Corp Injizierbare depotzusammensetzungen und deren verwendung
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
EA006939B1 (ru) 2001-12-18 2006-06-30 Юни-Фарма Клеон Цетис Фармасьютикал Лэборетериз С. А. Парентеральная композиция парацетамола
CN1171610C (zh) 2002-04-23 2004-10-20 张瑞香 一种治疗心脑血管和眼底病的中药针剂及其制备方法
US8871241B2 (en) 2002-05-07 2014-10-28 Psivida Us, Inc. Injectable sustained release delivery devices
EP1554304B1 (en) 2002-10-17 2009-06-10 The University Of British Columbia Ship 1 modulators
EP1558234B1 (en) 2002-10-25 2007-05-23 Dompé S.P.A. Painless injectable compositions containing salt of 2-arylpropionic acids
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
CN1507858A (zh) 2002-12-19 2004-06-30 王玉万 含氟化氯霉素的兽用液体制剂
CA2510196C (en) * 2002-12-20 2014-04-01 Generipharm, Inc. Intracutaneous injection
AU2003230899A1 (en) 2003-04-14 2004-11-26 Wyeth Holdings Corporation Compositions containing piperacillin and tazobactam useful for injection
DK1468697T3 (da) 2003-04-14 2008-04-14 Wyeth Corp Sammensætninger indeholdende piperacillin og tazobactam, der er anvendelige til injektion
KR100517643B1 (ko) 2003-07-25 2005-09-28 한국과학기술연구원 온도 감응성 폴리포스파젠계 고분자, 이의 제조방법 및이를 이용한 주입형 온도 감응성 폴리포스파젠 하이드로젤
SI1502589T1 (sl) 2003-07-31 2006-12-31 Emdoka Bvba Drug Registration Veterinarske vodne injektibilne suspenzije, ki vsebujejo florfenikol
US20050100538A1 (en) 2003-07-31 2005-05-12 Attawia Mohamed Intradiscal injection of anti-oxidants
JP4777067B2 (ja) 2003-08-22 2011-09-21 ジングルス・テヒノロギース・アクチェンゲゼルシャフト ディスク状基板の結合のための方法およびこの方法を実行するための装置
AU2004267882A1 (en) * 2003-09-01 2005-03-10 Mayne Pharma International Pty Ltd Compositions and methods for delivery of biologically active agents
JP2007504256A (ja) * 2003-09-01 2007-03-01 メイン・ファ−マ・インタ−ナショナル・プロプライエタリ−・リミテッド 生物活性剤の送達のための組成物及び方法
CN1856296A (zh) 2003-09-30 2006-11-01 阿库斯菲尔公司 可注射的、口服、或局部用缓释药物制剂
US20080145383A1 (en) 2004-03-12 2008-06-19 Intercell Ag Method for Solubilizing Peptide Mixtures
US20050240166A1 (en) 2004-04-26 2005-10-27 Microsolutions, Inc. Implantable device, formulation and method for anti-psychotic therapy using risperidone
MXPA06012992A (es) 2004-05-12 2007-02-12 Baxter Int Microesferas que comprenden proteina y que muestran inyectabilidad en altas concentraciones de este agente.
US20050261278A1 (en) * 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US20060160823A1 (en) 2004-05-28 2006-07-20 Leonore Witchey-Lakshmanan Particulate-stabilized injectable pharmaceutical compositions of Posaconazole
CA2580264A1 (en) 2004-09-13 2006-03-23 Pr Pharmaceuticals, Inc. Long acting injectable crystal formulations of estradiol metabolites and methods of using same
CN101437478A (zh) * 2004-10-04 2009-05-20 Qlt美国有限公司 聚合送递制剂的眼部送递
RU2007112675A (ru) * 2004-10-12 2008-11-20 Ф.Хоффманн-Ля Рош Аг (Ch) ПРОИЗВОДНЫЕ ИМИДАЗО[1,5-a]ТРИАЗОЛО[1,5-d]БЕНЗОДИАЗЕПИНА ДЛЯ ЛЕЧЕНИЯ КОГНИТИВНЫХ РАССТРОЙСТВ
AU2006208108A1 (en) 2005-01-27 2006-08-03 Erimos Pharmaceuticals Llc Oral formulations for delivery of catecholic butanes including NDGA compounds
US20080200383A1 (en) 2005-04-08 2008-08-21 Amylin Pharmaceuticals, Inc. Pharmaceutical Formulations Comprising Incretin Peptide and Aprotic Polar Solvent
US20080305161A1 (en) 2005-04-13 2008-12-11 Pfizer Inc Injectable depot formulations and methods for providing sustained release of nanoparticle compositions
US20070021411A1 (en) * 2005-05-11 2007-01-25 Cloyd James C Supersaturated benzodiazepine solutions and their delivery
BRPI0609191B8 (pt) 2005-06-17 2021-05-25 Ligand Pharm Inc métodos e compostos moduladores de receptor de androgênio
US8435224B2 (en) 2005-09-12 2013-05-07 Abela Pharmaceuticals, Inc. Materials for facilitating administration of dimethyl sulfoxide (DMSO) and related compounds
US20090156562A1 (en) * 2005-11-14 2009-06-18 Winch Peter D Novel colored solutions of injectable drugs and their pharmaceutically acceptable salts
WO2007084460A2 (en) 2006-01-18 2007-07-26 Qps, Llc Pharmaceutical compositions with enhanced stability
AR054215A1 (es) 2006-01-20 2007-06-13 Eriochem Sa Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
EP2001439A2 (en) * 2006-03-07 2008-12-17 Novavax, Inc. Nanoemulsions of poorly soluble pharmaceutical active ingredients and methods of making the same
WO2008051291A2 (en) * 2006-04-11 2008-05-02 Ordway Research Institute Nanoparticle and polymer formulations for thyroid hormone analogs, antagonists, and formulations thereof
EP2018883A4 (en) 2006-05-17 2009-05-13 Terumo Corp indwelling
WO2007140312A2 (en) 2006-05-25 2007-12-06 The General Hospital Corporation Anti-cross-linking agents and methods for inhibiting cross-linking of injectable hydrogel formulations
EP2063869B1 (en) 2006-09-07 2014-03-05 Merial Ltd. Soft chewable veterinary antibiotic formulations
US20100098735A1 (en) 2006-10-05 2010-04-22 Rajesh Jain Injectable depot compositions and its process of preparation
WO2008098212A2 (en) 2007-02-08 2008-08-14 Diobex, Inc. Extended release formulations of glucagon and other peptides and proteins
WO2008124522A2 (en) 2007-04-04 2008-10-16 Biodel, Inc. Amylin formulations
WO2008133908A2 (en) 2007-04-23 2008-11-06 Intarcia Therapeutics, Inc. Suspension formulations of insulinotropic peptides and uses thereof
JP5496082B2 (ja) 2007-04-30 2014-05-21 ノボ・ノルデイスク・エー/エス タンパク質組成物を乾燥させる方法、乾燥タンパク質組成物、及び乾燥タンパク質を含有する薬学的組成物
JP2010525033A (ja) 2007-04-30 2010-07-22 ノボ・ノルデイスク・エー/エス 高濃縮のインスリン溶液及び組成物
EP2030610A1 (en) * 2007-08-31 2009-03-04 Archimedes Development Limited Non-aqueous pharmaceutical compositions
BRPI0815773A2 (pt) * 2007-08-31 2019-09-24 Eisai R&D Man Co Ltd composto, e, medicamento.
CN101842079B (zh) * 2007-08-31 2012-09-05 阿基米德开发有限公司 非水性药物组合物
MX2010001911A (es) * 2007-08-31 2010-05-13 Archimedes Dev Ltd Composiciones farmaceuticas no acuosas.
US20090088393A1 (en) 2007-09-28 2009-04-02 Zomanex, Llc Methods and formulations for converting intravenous and injectable drugs into oral dosage forms
WO2009046444A2 (en) * 2007-10-05 2009-04-09 Mdrna, Inc. Formulation for intranasal administration of diazepam
CL2008003305A1 (es) 2007-11-06 2009-06-05 M/S Panacea Biotec Ltd Composicion inyectable que comprende un agente activo seleccionado de un grupo definido; al menos un polimero bioerosionable, al menos un solvente no toxico y opcionalmente uno o mas excipientes; proceso de preparacion; uso para tratar enfermedades mentales o cancer.
EP2060268A1 (en) 2007-11-15 2009-05-20 Novo Nordisk A/S Pharmaceutical compositions for pulmonary or nasal delivery of peptides
CA2702437C (en) 2007-11-28 2013-06-25 Teva Pharmaceutical Industries Ltd. Method of delaying the onset of clinically definite multiple sclerosis
CA2711984A1 (en) 2008-01-15 2009-07-23 Abbott Gmbh & Co. Kg Powdered protein compositions and methods of making same
KR101517415B1 (ko) 2008-05-14 2015-05-07 에스케이바이오팜 주식회사 난용성 항경련제를 함유하는 경비 항경련성 약학 조성물
CA2731353A1 (en) 2008-07-23 2010-02-18 Bharat Serums & Vaccines Ltd. Stable injectable oil-in-water docetaxel nanoemulsion
GB0815435D0 (en) 2008-08-22 2008-10-01 Camurus Ab Formulations
AU2009285115A1 (en) 2008-08-25 2010-03-04 Denki Kagaku Kogyo Kabushiki Kaisha Syringe
CA2735899A1 (en) 2008-09-25 2010-04-01 Cephalon, Inc. Liquid formulations of bendamustine
US20110118578A1 (en) 2009-11-17 2011-05-19 Roche Diagnostics Operations, Inc. Hypoglycemic treatment methods and systems
US20110223208A1 (en) 2010-03-09 2011-09-15 Beth Hill Non-Aqueous High Concentration Reduced Viscosity Suspension Formulations
GB2513060B (en) 2010-06-08 2015-01-07 Rb Pharmaceuticals Ltd Microparticle buprenorphine suspension
WO2012012460A1 (en) 2010-07-19 2012-01-26 Xeris Pharmaceuticals, Inc. Stable glucagon formulations for the treatment of hypoglycemia
JP5632226B2 (ja) 2010-07-30 2014-11-26 株式会社細川洋行 医療用多層チューブ、および医療用輸液バッグ
AU2012225268B2 (en) 2011-03-10 2016-10-20 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of peptide drugs
CA2831308A1 (en) * 2011-03-31 2012-10-04 Sk Biopharmaceuticals Co., Ltd. Intranasal benzodiazepine pharmaceutical compositions
ES2683902T3 (es) * 2011-06-14 2018-09-28 Hale Biopharma Ventures, Llc Administración de benzodiacepina
EA027744B1 (ru) 2011-10-31 2017-08-31 Ксерис Фармасьютикалс, Инк. Лекарственные формы для лечения сахарного диабета
EP2849723B1 (en) 2012-05-18 2018-05-02 Genentech, Inc. High-concentration monoclonal antibody formulations
US9522235B2 (en) 2012-05-22 2016-12-20 Kaleo, Inc. Devices and methods for delivering medicaments from a multi-chamber container
US9125805B2 (en) * 2012-06-27 2015-09-08 Xeris Pharmaceuticals, Inc. Stable formulations for parenteral injection of small molecule drugs
AU2013308693A1 (en) 2012-08-29 2015-03-12 Mannkind Corporation Method and composition for treating hyperglycemia
US9018162B2 (en) 2013-02-06 2015-04-28 Xeris Pharmaceuticals, Inc. Methods for rapidly treating severe hypoglycemia
US20160000803A1 (en) * 2013-02-22 2016-01-07 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for transmucosal administration of benzodiazepines
EP2958594A4 (en) * 2013-02-22 2017-03-01 Eastgate Pharmaceuticals Inc. Pharmaceutical composition for enhanced transmucosal administration of benzodiazepines
UA119324C2 (uk) * 2013-04-02 2019-06-10 Теміс Медікер Лімітед Композиції фармацевтично активних речовин, що містять моноетиловий ефір діетиленгліколю або інші алкільні похідні
CN104706589A (zh) * 2013-12-16 2015-06-17 天津迈迪瑞康生物医药科技有限公司 一种地西泮药物组合物、其制备方法及用途
KR102327754B1 (ko) 2014-02-06 2021-11-17 엑스에리스 파머수티클스, 인크. 안정한 펩티드 제형물 및 제조 방법
WO2015153728A1 (en) 2014-04-02 2015-10-08 Xeris Pharmaceuticals, Inc. Polar aprotic solvent-compatible infusion sets, components, and methods
WO2016022831A1 (en) 2014-08-06 2016-02-11 Xeris Pharmaceuticals, Inc. Syringes, kits, and methods for intracutaneous and/or subcutaneous injection of pastes
WO2016196976A1 (en) 2015-06-04 2016-12-08 Xeris Pharmaceuticals, Inc. Glucagon delivery apparatuses and related methods
EP3307295A1 (en) 2015-06-10 2018-04-18 Xeris Pharmaceuticals, Inc. Use of low dose glucagon
NL2017110B1 (en) * 2016-07-05 2018-01-12 Emp Levo Gmbh Methods for the preparation of a levothyroxine solution
KR20240036128A (ko) 2017-06-02 2024-03-19 엑스에리스 파머수티클스, 인크. 침전 방지 저분자 약물 제제

Similar Documents

Publication Publication Date Title
JP2020522502A5 (https=)
ES2624442T5 (en) Pharmaceutical compositions of pemetrexed
SK12993A3 (en) Pharmaceutical composition of florfenicol
FI3506886T3 (fi) Erittäin väkevöityjä alhaisen viskositeetin masp-2:ta estäviä vasta-aineformulaatioita, tarvikesarjoja ja menetelmiä
IL275388B2 (en) Liquid protein formulations containing viscosity reducing agents
WO2009111057A4 (en) Fulvestrant formulations
CA2609242A1 (en) Injectable compositions and process for preparation of such compositions
WO2016059592A1 (en) Stable injectable composition of peptide drugs and process for its preparation
JP2019537589A5 (https=)
JP2022534291A (ja) 非プロトン性極性溶媒中の安定な治療用組成物およびその製造方法
EP2205215A2 (en) Docetaxel injectable composition, being absolutely free of ethanol
JP2007515425A (ja) 医薬組成物
JP2014502282A (ja) 安定な使用準備済みセトロレリックス注射液
JP2015520762A5 (https=)
ES2315942T3 (es) Composicion veterinaria inyectable que contiene florfenicol.
JPS605567B2 (ja) オキシテトラサイクリンの調合液
ZA200306391B (en) Suspension of ceftiofur hydrochloride.
JP5217136B2 (ja) 直腸、尿道および膣適用用半固形状製剤。
KR100548948B1 (ko) 플로르페니콜의 약제학적 조성물
CA3143663A1 (en) A stable formulation of cetrorelix
KR940000066B1 (ko) 약제학적 제제
US3220923A (en) Aqueous injectable compositions and methods for effecting narcosis
EP4164608A1 (en) Pharmaceutical compositions
CN101155584A (zh) 给药伊沙匹隆的方法
BRPI0621841B1 (pt) formulação líquida